Program

Strategiebericht

Final Program

Infectious Diseases in the 21st Century

Download PDF

Final Program

 

Wednesday 24. October

11:30     Arrival, Registration, Refreshments

12:30     Opening remarks by Walter Rosenthal

12:45     Opening remarks by Wolfgang Tiefensee

13:00     Opening remarks by Axel Brakhage

13:10     Vaccines and host-based Therapies

Rino Rappuoli | GlaxoSmithKline

Vaccines, an achievement of civilization and health insurance for the future

Stefan Kaufmann | Max Planck Institute for Infection Biology

The TB vaccine VPM1002: from drawing board to clinical efficacy testing

Alexander Scheffold | Charité – Universitätsmedizin Berlin

Pathogen-specific T cells reveal the host-pathogen interaction status

Carlos Guzmán | Helmholtz Centre for Infection Research

Tailoring immune responses to vaccines

15:00     Coffee break
15:30     InfectControl 2020: One Health

Thomas Mettenleiter | Friedrich-Loeffler-Institut

One medicine – One health - One planet

Fabian Leendertz | Robert Koch Institute

Identifying innovative Sentinels for emerging infectious diseases

Petra Gastmeier | Charité – Universitätsmedizin Berlin

Better use of antibiotics by better information and communication

17:00     Coffee break
17:30     Barriers to Development and Clinical Research

Helga Rübsamen-Schaeff | AiCuris

Lessons from Virology: How can Research for Resistance-Breaking Antibiotics be improved?

Thomas Sudhop | Federal Institute for Drugs and Medical Devices

How can regulators foster new developments?

18:30     Coffee break
18:45     Evening Lecture

Harald zur Hausen | German Cancer Research Center

Specific infections causing random mutations – concept and data for human colon and breast cancers

19:45     Reception

 

Thursday 25. October

09:00     Epidemiology and Public Health

Flavia Machado | Federal University of São Paulo

Sepsis: a global threat that needs a global solution

Petra Dickman | Jena University Hospital

Public Health and Health Security - re-thinking the societal challenges

of infectious disease

10:00     Coffee break
10:30     Pandemics

Christian Drosten | Charité – Universitätsmedizin Berlin

MERS, Zika, and other puzzles in global infectious diseases

Richard Neher | Biozentrum, University Basel

Real-time tracking of RNA virus evolution and spread

Stephan Günther | Bernhard Nocht Institute for Tropical Medicine

Viral hemorrhagic fevers in Africa: Research and disease control

12:00     Lunch
13:00     Antimicrobial Resistances

Lothar Wieler | Robert Koch Institute

Stemming the tide of antimicrobial resistances: conservation through innovation

Rotem Sorek | Weizmann Institute of Science

Regulation of antibiotic resistance with small RNA sensors

14:00     Antibiotics and Anti-Infectives

Christian Hertweck | Leibniz Institute for Natural Product Research and Infection Biology

Antimicrobial discovery inspired by ecological interactions

Helen Zgurskaya | University of Oklahoma

Molecular determinants of antibiotic activities and permeation in Gram-negative bacteria

15:00     Coffee break
15:30     Pathogenicity and Genomics

Pascale Cossart | Institut Pasteur

New insights in Listeria pathogenicity

Bernhard Hube | Leibniz Institute for Natural Product Research and Infection Biology

Virulence or avirulence? Dual function genes in Candida albicans

Carmen Buchrieser | Institut Pasteur

17:00     Coffee break
17:15     Pathogenicity and Genomics

Ron Fouchier | Erasmus Medical Center

Molecular determinants of pathogenicity and transmission of influenza viruses

Julian Parkhill | Sanger Institute

Signatures of emergence and transmission in bacterial pathogens

19:00     Conference Dinner (invited guest only)

 

Friday 26. October

09:00     Infections in the Media

Volker Stollorz | Science Media Center

Infectious media: Why and when outbreaks get viral?

09:30     Diagnostics

January Weiner | Max Planck Institute for Infection Biology

Predicting the onset of tuberculosis with host biomarkers

Alexander Mellmann | University of Münster

Real-Time Genome Sequencing of Resistant Bacteria Provides Precise Infection Control

Susanne Häußler | Helmholtz Centre for Infection Research

Antimicrobial Resistance Profiling in Gram-negative Pathogens

11:00     Coffee break
11:30     Demand and Market

Jochen Maas | Sanofi

Research on anti-infectives and antibiotics: Is it still economically attractive?

12:00     Evolution of Man and Microbe

Johannes Krause | Max Planck Institute for the Science of Human History

The genetic history of the Plague: From the Stone Age to the 18th century

12:30     Lunch and Departure